Truncal acne has historically been overlooked in clinical evaluations and trials, resulting in a lack of evidence-based treatment options

Despite the lack of randomized clinical trials and treatment guidelines involving the trunk, we have typically relied on benzoyl peroxide washes, oral antibiotics, and isotretinoin for truncal acne treatment

Some progress has been made in recent years with certain trials including truncal acne evaluation, for example lidose-isotretinoin, sarecycline, dapsone, and trifarotene

Trifarotene is the first topical retinoid with robust evidence from large-scale, randomized, vehicle-controlled phase III studies, supporting its use as a first-line acne treatment for both the face and trunk

It is time we consider evidence-based treatments for our patients with combined facial and truncal acne, to help improve outcomes and relieve the burden on their lives